BioNTech SE Ratios

Ratios Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 84.87%89.27%84.00%87.70%84.66%82.70%84.29%80.32%
EBT Margin -139.46%-37.36%-165.19%-30.23%79.29%74.83%31.06%-24.63%
EBIT Margin -99.48%-42.21%-167.13%-17.08%80.54%73.03%18.08%-47.77%
EBITDA Margin -99.48%-42.21%-167.13%-17.08%80.54%73.03%18.08%-47.77%
Operating Margin -99.48%-42.21%-167.13%-17.08%80.54%73.03%18.08%-47.77%
Net Margin -139.05%-37.64%-164.92%3.15%54.24%54.50%24.36%-24.18%
FCF Margin -124.81%-69.59%-218.32%-16.48%4.02%76.53%134.12%-2.86%
Efficiency
Inventory Average 0.01B0.04B0.33B0.51B0.42B0.34B
Assets Average 0.83B1.82B10.44B20.93B24.25B24.41B
Equity Average 0.13B0.43B1.09B7.62B17.03B21.12B21.26B
Invested Capital 0.00B0.38B0.63B1.96B15.50B21.69B22.23B22.29B
Asset Utilization Ratio 0.150.322.080.840.170.12
Leverage & Solvency
Interest Coverage Ratio -2.36-0.00B-90.75-1.2750.09668.9328.89-47.97
Debt to Equity 0.230.160.220.140.040.020.08
Debt Ratio 0.100.100.130.100.030.020.07
Equity Ratio 0.410.620.590.750.860.880.86
Times Interest Earned -2.36-0.00B-90.75-1.2750.09668.9328.89-47.97
Dividends & Payouts
FCF Payout Ratio 0.04
Valuation
Enterprise Value -0.19B-0.49B7.09B16.88B46.46B22.16B7.28B9.38B
Market Capitalization 7.67B18.49B63.00B36.51B25.09B27.32B
Return Ratios
Return on Sales -1.40%-0.38%-1.65%0.03%0.54%0.55%0.24%-0.24%
Return on Capital Employed -0.30%-0.09%2.71%0.72%0.03%-0.06%
Return on Invested Capital -0.40%1.37%0.51%0.03%-0.06%
Return on Assets -0.24%0.01%1.13%0.46%0.04%-0.03%
Return on Equity -0.44%-0.46%0.02%1.55%0.57%0.05%-0.03%